SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community eagerly anticipates the upcoming LitVM mainnet rollout, which is expected to significantly expand its utility with smart contract capabilities for DeFi, NFTs, and AI applications. This transformative upgrade is widely seen as a potential catalyst to reframe Litecoin's valuation beyond a simple payment coin, amidst ongoing discussions about decreasing exchange liquidity and growing institutional interest in the broader crypto ecosystem.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amid intense discussion over increased competition in the weight loss sector, particularly with Amazon Pharmacy now directly offering a major competitor's oral GLP-1 drug, which is notably not available on HIMS' platform. This, coupled with a recent analyst downgrade citing concerns about future margins and investment, has sparked a polarized debate among investors, with many bulls highlighting high short interest and long-term growth initiatives while bears foresee further declines.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending following a significant agreement with Meta Platforms to develop 1.2 GW of nuclear energy to power AI data centers, marking a major validation for its advanced reactor technology. Proponents are enthusiastic about the long-term potential, Meta's strategic prepayment, and ongoing government support for future energy infrastructure. However, some market observers remain cautious, citing the distant operational timelines and lack of immediate revenue as points of concern amid the broader AI-driven demand for clean power.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is trending after securing a significant DOE agreement for Project TETRA, a pilot reactor initiative set to fast-track its Generation IV molten salt reactor technology. The community is comparing its undervalued position relative to peers like OKLO, citing regulatory progress and standard fuel advantages. Investors anticipate substantial upside as the company progresses in the critical advanced nuclear sector, driven by increasing energy demands from AI and government support for rapid deployment.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

ZEC is trending due to intense community debate following news of a core dev team transition, with narratives ranging from strategic regrouping to abandonment, creating market volatility. Adding to the buzz, institutional players like Cypherpunk Technologies are increasing their ZEC holdings and Grayscale has filed for a spot ETF, fueling anticipation for the privacy-focused coin's future amidst regulatory discussions.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending due to a recent analyst upgrade to "Top Pick" and widespread anticipation of an imminent announcement regarding a strategically significant partnership, particularly for its burgeoning Federal and Sovereign AI divisions. The community views INOD as a deeply undervalued "picks-and-shovels" AI firm, poised for substantial growth in critical data engineering initiatives, further fueled by bullish chart patterns and significant short interest.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals is experiencing extreme volatility and a massive price surge, with much of the community speculating on a potential pivot to blockchain-based assets under its new CEO, Michael Kazley. While bullish investors celebrate substantial gains and anticipate further short squeeze action due to a tight float, a significant portion of the community expresses skepticism, labeling the rapid ascent a "pump and dump" lacking clear fundamental justification.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending with shareholders debating executive compensation after recent share grants, contrasting with strong optimism for the company's Briumvi drug. Community sentiment is mixed as many anticipate positive catalysts from the upcoming JP Morgan Healthcare Conference and reduced competition in the MS market following a rival's regulatory setback.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending as the market reacts to its new CEO, Tom Stepien, and the company's prominent presence at CES showcasing advanced silicon-anode batteries. Community discussion centers on a strategic shift towards scalable manufacturing via its expanded Korean alliance, seen as a catalyst for securing key contracts in defense, electric aviation, and commercial drone sectors. This focus on execution and market penetration is fueling long-term bullish sentiment, even amidst ongoing market volatility.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos (ATOM) is trending amid active discussions surrounding a proposed tokenomics redesign aimed at transitioning to a revenue-based model, alongside recent speculation about potential ETF filings for its ecosystem. This comes as the community remains divided, with strong bullish sentiment from those attracted to its high staking rewards and role as the 'Internet of Blockchains,' while others express skepticism over past price performance and its ability to keep pace with broader market rallies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ANI Pharmaceuticals (NASDAQ:ANIP) Trading Down 6.3% - Time to Sell?

ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Down 6.3% - Time to Sell...

ALT Stock Up 17% After Pemvidutide Gets FDA Breakthrough Tag for MASH

Altimmune shares rally 16.52% after the FDA grants Breakthrough Therapy status to pemvidutide for MASH. 

Celcuity Stock Up 677% in 6 Months: What's Behind This Huge Increase?

CELC shares surge as NDA filing and strong phase III data boost optimism around gedatolisib's potential.

ANIP Up 21% in 6 Months: Is It Worth Investing in the Stock Now?

ANI Pharmaceuticals' shares are up 21% in six months as strong 2025 results, repeated earnings beats and higher guidance highlight momentum in rare diseases.

ZBIO Tanks Despite Positive Data From Rare Autoimmune Diseases Study

Zenas BioPharma tanks nearly 52% despite positive INDIGO study data where obexelimab cut IgG4-RD flare risk by 56% and met all key endpoints.

INCY's Phase III Monjuvi Study Meets Key Goals in First-Line Lymphoma

Incyte's phase III study of Monjuvi combo for first-line DLBCL treatment met primary and key secondary goals, paving the way for a 2026 FDA filing.

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine brokerages that are covering the stock, MarketBeat Ratings...

Intellia Stock Declines Around 55% in 3 Months: Here's Why

NTLA shares plunge 55% in three months after the FDA placed a clinical hold on Nex-Z, suspending trials and milestone guidance following the death of a patient.

Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026

IRWD shares jump on upbeat 2026 revenue guidance amid rising Linzess demand in the United States. The company also provides a key pipeline update.

FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children

Sanofi wins FDA priority review to expand Tzield's use to children as young as one, aiming to delay type 1 diabetes progression.

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

ANI Pharmaceuticals Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

ANIP
ANI Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ANIP News

ANIPANI Pharmaceuticals Inc